Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
Heart Failure – Demystifying Pharmacological Management for GPs
Iron Deficiency in Children & Young People
Heart Failure – Assessment and Monitoring in Primary Care
COPD Update
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis